Intensity Therapeutics, Inc. (INTS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 139.16M |
| Enterprise Value | 127.35M |
| P/E Ratio | -0.56 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9.99 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.87 |
| Return On Equity | -1.37 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -26,000 |
| EBITDA | -11.61M |
| Net Income | -11.61M |
| Diluted EPS | -8.56 |
| Total Cash | 10.25M |
| Total Cash/Share | 0.4 |
| Total Debt | 102,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.86 |
| Book Value Per Share | 0.39 |
| 52-Week Change | -47.18 |
| 52-Week High | 43.5 |
| 52-Week Low | 3.51 |
| Moving Average 50 Days | 4.67 |
| Moving Average 200 Days | 7.67 |
| Average Volume | 29,680 |
| Shares Outstanding | 1.89M |
| % Held by Institutions | 0.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | February 19, 2026 |